6. COMMITMENTS AND CONTINGENCIES (Details Narrative)	9 Months Ended
Sep. 30, 2019 USD ($)	Sep. 30, 2019 EUR (€)	Dec. 31, 2018 USD ($)
Accrued licensing fees \| $	$ 622,000		$ 652,000
Dr. Wiedow [Member]
Licensing fee maturity date	Nov. 15, 2020
Dr. Wiedow [Member] \| Euro [Member]
Accrued licensing fees \| €		€ 570,000

Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Name:	us-gaap_DebtInstrumentMaturityDate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration